Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study
- PMID: 33411707
- PMCID: PMC7790269
- DOI: 10.1371/journal.pone.0244532
Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study
Erratum in
-
Correction: Mortality and other outcomes of patients with coronavirus disease pneumonia admitted to the emergency department: A prospective observational Brazilian study.PLoS One. 2021 Mar 4;16(3):e0248327. doi: 10.1371/journal.pone.0248327. eCollection 2021. PLoS One. 2021. PMID: 33662001 Free PMC article.
Abstract
Background: The first cases of coronavirus disease (COVID-19) in Brazil were diagnosed in February 2020. Our Emergency Department (ED) was designated as a COVID-19 exclusive service. We report our first 500 confirmed COVID-19 pneumonia patients.
Methods: From 14 March to 16 May 2020, we enrolled all patients admitted to our ED that had a diagnosis of COVID-19 pneumonia. Infection was confirmed via nasopharyngeal swabs or tracheal aspirate PCR. The outcomes included hospital discharge, invasive mechanical ventilation, and in-hospital death, among others.
Results: From 2219 patients received in the ED, we included 506 with confirmed COVID-19 pneumonia. We found that 333 patients were discharged home (65.9%), 153 died (30.2%), and 20 (3.9%) remained in the hospital. A total of 300 patients (59.3%) required ICU admission, and 227 (44.9%) needed invasive ventilation. The multivariate analysis found age, number of comorbidities, extension of ground glass opacities on chest CT and troponin with a direct relationship with all-cause mortality, whereas dysgeusia, use of angiotensin converting enzyme inhibitor or angiotensin-ii receptor blocker and number of lymphocytes with an inverse relationship with all-cause mortality.
Conclusions: This was a sample of severe patients with COVID-19, with 59.2% admitted to the ICU and 41.5% requiring mechanical ventilator support. We were able to ascertain the outcome in majority (96%) of patients. While the overall mortality was 30.2%, mortality for intubated patients was 55.9%. Multivariate analysis agreed with data found in other studies although the use of angiotensin converting enzyme inhibitor or angiotensin-ii receptor blocker as a protective factor could be promising but would need further studies.
Trial registration: The study was registered in the Brazilian registry of clinical trials: RBR-5d4dj5.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- World Health Organization. Novel coronavirus (2019-nCoV): situation report—15. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... = 88fe8ad6_4
-
- Worldometers. Coronavirus infections update 2020 [cited 2020 May 31, 2020]. Available from: http://www.worldometers.info/coronavirus/.
-
- World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020. Available from: https://apps.who.int/iris/handle/10665/331446?search-result=true&query=1...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical